Literature DB >> 17934080

Optimal use of methotrexate: the advantages of tight control.

J W J Bijlsma, M E Weinblatt.   

Abstract

The CAMERA study shows that using methotrexate in a tight control setting might lead to considerable improvement in disease activity in early rheumatoid arthritis See linked article p 1443.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17934080      PMCID： PMC2111621          DOI： 10.1136/ard.2007.076463

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  14 in total

Review 1.  Treating rheumatoid arthritis early: a window of opportunity?

Authors:  James R O'Dell
Journal:  Arthritis Rheum       Date:  2002-02

2.  Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.

Authors:  T Möttönen; P Hannonen; M Leirisalo-Repo; M Nissilä; H Kautiainen; M Korpela; L Laasonen; H Julkunen; R Luukkainen; K Vuori; L Paimela; H Blåfield; M Hakala; K Ilva; U Yli-Kerttula; K Puolakka; P Järvinen; M Hakola; H Piirainen; J Ahonen; I Pälvimäki; S Forsberg; K Koota; C Friman
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

3.  A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.

Authors:  J M Bathon; R W Martin; R M Fleischmann; J R Tesser; M H Schiff; E C Keystone; M C Genovese; M C Wasko; L W Moreland; A L Weaver; J Markenson; B K Finck
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

4.  Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

Authors:  Lars Klareskog; Désirée van der Heijde; Julien P de Jager; Andrew Gough; Joachim Kalden; Michel Malaise; Emilio Martín Mola; Karel Pavelka; Jacques Sany; Lucas Settas; Joseph Wajdula; Ronald Pedersen; Saeed Fatenejad; Marie Sanda
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

5.  The BeSt way to treat early rheumatoid arthritis?

Authors:  James R O'Dell
Journal:  Ann Intern Med       Date:  2007-03-20       Impact factor: 25.391

6.  The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.

Authors:  Ferdinand C Breedveld; Michael H Weisman; Arthur F Kavanaugh; Stanley B Cohen; Karel Pavelka; Ronald van Vollenhoven; John Sharp; John L Perez; George T Spencer-Green
Journal:  Arthritis Rheum       Date:  2006-01

7.  Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Amalia A van Everdingen; Johannes W G Jacobs; Dirk R Siewertsz Van Reesema; Johannes W J Bijlsma
Journal:  Ann Intern Med       Date:  2002-01-01       Impact factor: 25.391

Review 8.  Remission of rheumatoid arthritis: should we care about definitions?

Authors:  D Aletaha; J S Smolen
Journal:  Clin Exp Rheumatol       Date:  2006 Nov-Dec       Impact factor: 4.473

9.  Rationale and strategies for reevaluating the ACR20.

Authors:  David T Felson; Daniel E Furst; Maarten Boers
Journal:  J Rheumatol       Date:  2007-05       Impact factor: 4.666

10.  The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.

Authors:  A van der Heide; J W Jacobs; J W Bijlsma; A H Heurkens; C van Booma-Frankfort; M J van der Veen; H C Haanen; D M Hofman; G A van Albada-Kuipers; E J ter Borg; H L Brus; H J Dinant; A A Kruize; Y Schenk
Journal:  Ann Intern Med       Date:  1996-04-15       Impact factor: 25.391
View more
  8 in total

1.  Radiographic quantifications of joint space narrowing progression by computer-based approach using temporal subtraction in rheumatoid wrist.

Authors:  Shota Ichikawa; Tamotsu Kamishima; Kenneth Sutherland; Takanobu Okubo; Kou Katayama
Journal:  Br J Radiol       Date:  2015-10-20       Impact factor: 3.039

2.  Racial disparities in treatment preferences for rheumatoid arthritis.

Authors:  Florina Constantinescu; Suzanne Goucher; Arthur Weinstein; Liana Fraenkel
Journal:  Med Care       Date:  2009-03       Impact factor: 2.983

3.  A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis.

Authors:  Jeannine M Heckmann; Amanullah Rawoot; Kathleen Bateman; Rudi Renison; Motasim Badri
Journal:  BMC Neurol       Date:  2011-08-05       Impact factor: 2.474

4.  Determining the Lowest Optimally Effective Methotrexate Dose for Individual RA Patients Using Their Dose Response Relation in a Tight Control Treatment Approach.

Authors:  Sandhya C Nair; Johannes W G Jacobs; Marije F Bakker; Z Nazira Jahangier; Johannes W J Bijlsma; Jacobs M van Laar; Floris P J G Lafeber; Paco M J Welsing
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

5.  CDK7 inhibition suppresses rheumatoid arthritis inflammation via blockage of NF-κB activation and IL-1β/IL-6 secretion.

Authors:  Honghai Hong; Yingmin Zeng; Wenxuan Jian; Lei Li; Liying Lin; Yousheng Mo; Meiling Liu; Shuhuan Fang; Yong Xia
Journal:  J Cell Mol Med       Date:  2017-10-30       Impact factor: 5.310

6.  TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol.

Authors:  Ellis Niemantsverdriet; Yousra J Dakkak; Leonie E Burgers; Femke Bonte-Mineur; Gerda M Steup-Beekman; Sjoerd M van der Kooij; Hido D Boom; Cornelia F Allaart; Pascal H P de Jong; Annette H M van der Helm-van Mil
Journal:  Trials       Date:  2020-10-16       Impact factor: 2.279

7.  A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis.

Authors:  Leander R Buisman; Jolanda J Luime; Mark Oppe; Johanna M W Hazes; Maureen P M H Rutten-van Mölken
Journal:  Arthritis Res Ther       Date:  2016-06-10       Impact factor: 5.156

8.  Chinese Herbal Medicines for Rheumatoid Arthritis: Text-Mining the Classical Literature for Potentially Effective Natural Products.

Authors:  Xuan Xia; Brian H May; Anthony Lin Zhang; Xinfeng Guo; Chuanjian Lu; Charlie C Xue; Qingchun Huang
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-28       Impact factor: 2.629
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.